ArthritoMab™ Antibody Cocktail Guide and Data Pack

 

Get Steady and Controlled Disease Progression with only 2 mg ArthritoMab™ Antibody Cocktail

The collagen antibody-induced arthritis model (CAIA) is an excellent alternative model for evaluating compounds for efficacy in rheumatoid arthritis. Companies no longer need to wait 42 days for results or carry special colonies as is the case in the Collagen-induced arthritis (CIA) model and the K/BxN models respectively.

Fill out the form and we will email you the data pack to learn more about the benefits of the anti-collagen induced arthritis model:

  • Eliminate variability
  • No expensive colonies
  • Synchronized disease
  • Steady and controlled disease
  • Results in 12 days
  • Susceptible in a variety of strains including C57BL/6
  • Histopathological similarities to CIA

 

Optimized to use less antibody with C57Bl/6

Hyperplasia and cellular infiltration

The use of transgenic strains often require higher amounts of induction reagents or altered protocols to achieve acceptable levels of disease. MD Bioproducts has optimized the ArthritoMab™ antibody cocktail for use in transgenic strains to eliminate the need for substantially higher amounts of antibody.

 

 

 

 

 

 

Get the whitepaper and data pack